研究结果:HIV PrEP队列(n=327)和HIV感染者队列(n=174)细菌性STI的相对风险(RR)均有所降低,包括淋病(RR 0.45,95%CI:0.34～0.65;RR 0.45,95%CI:0.34～0.65)、衣原体(RR 0.12,95%CI:0.05～0.25;RR 0.26,95%CI:0.12～0.57)和梅毒(RR 0.13,...
Updated: Jan 17, 2023 Author: Rachel Weihe, MD; more...HIV Treatment Guidelines per the Centers for Disease Control The Centers for Disease Control (CDC) and other federal government agencies have issued several guidelines and recommendations regarding the prevention, screening, diagnosis, treatment,...
研究结果:HIV PrEP队列(n=327)和HIV感染者队列(n=174)细菌性STI的相对风险(RR)均有所降低,包括淋病(RR 0.45,95%CI:0.34～0.65;RR 0.45,95%CI:0.34～0.65)、衣原体(RR 0.12,95%CI:0.05～0.25;RR 0.26,95%CI:0.12～0.57)和梅毒(RR 0.13,95%CI:0.03～0.59;RR 0.23,95%CI:0.04～1.29)。 法国ANRS D...
BackgroundPre-exposure prophylaxis (PrEP) has emerged as an HIV prevention tool for populations at highest risk for HIV infection. Current CDC guidelines f... MR Beymer,RE Weiss,CA Sugar,... - 《Sexually Transmitted Diseases》 被引量: 3发表: 2017年 ...
The article presents information about ChioraPrep, which is a preoperative skin preparatory. The product is the first U.S. Food and Drug Administration approved presurgical topical agent that ...
Citing agrowing supply of the shots, federal health officials said they are now moving to a "pre-exposure prophylaxis" or PrEP approach to vaccine eligibility — meaning offering it to people as a preventive measure before they had any known exposure. ...
CD4+ T cells can "help” or "license” conventional type 1 dendritic cells (cDC1s) to induce CD8+ cytotoxic T lymphocyte (CTL) anticancer responses, as proven in mouse models. We recently identified cDC1s with a transcriptomic imprint of CD4+ T-cell help
当提供Doxy PEP时,应结合全面性健康方法来实施,包括降低风险咨询、STI筛查和治疗、推荐疫苗接种,以及与HIV PrEP、HIV照护或其他适当服务的联系。接受Doxy PEP治疗的个体,应在基线时和此后每3～6个月进行暴露部位的细菌性STI检测。应根据当前建议为HIV阴性的MSM和TGW进行HIV筛查。
当提供Doxy PEP时,应结合全面性健康方法来实施,包括降低风险咨询、STI筛查和治疗、推荐疫苗接种,以及与HIV PrEP、HIV照护或其他适当服务的联系。接受Doxy PEP治疗的个体,应在基线时和此后每3～6个月进行暴露部位的细菌性STI检测。应根据当前建议为HIV阴性的MSM和TGW进行HIV筛查。